stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) Return on equity
Teleflex Incorporated's return on equity over the twelve months to 30 June 2026 was −28.9%, down 4.4 percentage points from fiscal 2025 (−24.5%). Over the past ten years it has ranged from −24.5% (fiscal 2025) to 16.7% (fiscal 2019) — the current reading is the lowest in ten years. That is below the Medical Instruments & Supplies industry median of 0.00% and below the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | −24.5% | (26.07) |
| FY2024 | 1.60% | (6.82) |
| FY2023 | 8.42% | (0.92) |
| FY2022 | 9.34% | (4.35) |
| FY2021 | 13.7% | 3.07 |
| FY2020 | 10.6% | (6.10) |
| FY2019 | 16.7% | 8.64 |
| FY2018 | 8.08% | 1.40 |
| FY2017 | 6.68% | (4.76) |
| FY2016 | 11.4% | (1.04) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| NVST Envista Holdings Corporation compare | 20.5% |
| ATR AptarGroup, Inc. compare | 9.86% |
| MMSI Merit Medical Systems, Inc. compare | 9.78% |
| AVTR Avantor, Inc. compare | 5.91% |
| ICUI ICU Medical, Inc. compare | 2.79% |
| MMED MiniMed Group, Inc. compare | 0.00% |
| BLCO Bausch + Lomb Corporation compare | −1.71% |
| TFX Teleflex Incorporated | −28.9% |
| PLSE Pulse Biosciences, Inc compare | −60.7% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on TFX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement